Tomayo I Berida

6PUBLICATIONS
12CO-AUTHORS
Biomolecular modelling and designBiologically active moleculesMajor global burdens of diseaseVeterinary pharmacologyCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 22, 2025
1,2,4-Triazole-Based First-in-Class Non-Nucleoside Inhibitors of the Bacterial Enzyme MraY.

Tomayo Berida, Tzu-Yu Huang, Stefanie C Weck

|Jun 30, 2025
Total Synthesis of Kavaratamides A-C and Unnatural Analogs.

Tomayo I Berida, Craig W Lindsley

|Dec 09, 2024
Move over COVID, Tuberculosis Is Once again the Leading Cause of Death from a Single Infectious Disease.

Tomayo Berida, Craig W Lindsley

|Oct 15, 2024
Classics in Chemical Neuroscience: Medetomidine.

Pedro de Andrade Horn, Tomayo I Berida, Lauren C Parr

|Oct 03, 2023
Discovery, Synthesis, and Optimization of 1,2,4-Triazolyl Pyridines Targeting Mycobacterium tuberculosis.

Tomayo Berida, Samuel R McKee, Shamba Chatterjee

|Dec 23, 2020
Identification of potential non-nucleoside MraY inhibitors for tuberculosis chemotherapy using structure-based virtual screening.

Pankaj Pandey, Shamba Chatterjee, Tomayo Berida

Pageof 1